Rhythm Pharmaceuticals, Inc.
RYTMNASDAQHealthcare● Active
$85.93
$-0.48(-0.55%)
Market Cap$5.9B
P/E Ratio—
52W High$122.2
52W Low$60.7
Rhythm Pharmaceuticals, Inc.（RYTM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RYTM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19B | $0.13B | $0.08B | $0.02B | $0.00B |
| Cost of Revenue | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Gross Profit | $0.17B | $0.12B | $0.07B | $0.02B | $0.00B |
| Gross Margin %(computed) | 89.73% | 89.73% | 87.99% | 90.98% | 81.01% |
| Operating Expenses | |||||
| R&D Expenses | $0.17B | $0.24B | $0.13B | $0.11B | $0.10B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.36B | $0.38B | $0.25B | $0.20B | $0.17B |
| Operating Income | ($0.19B) | ($0.27B) | ($0.18B) | ($0.18B) | ($0.17B) |
| Operating Margin %(computed) | -101.19% | -204.04% | -238.10% | -757.92% | — |
| Interest Income | $0.02B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | ($0.20B) | ($0.26B) | ($0.18B) | ($0.18B) | ($0.07B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.20B) | ($0.26B) | ($0.18B) | ($0.18B) | ($0.07B) |
| Net Margin %(computed) | -103.57% | -200.27% | -238.52% | -766.22% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.11 | $-4.34 | $-3.20 | $-3.51 | $-1.37 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.17B) | ($0.24B) | ($0.17B) | ($0.17B) | ($0.07B) |
| EBITDA Margin %(computed) | -91.76% | -182.97% | -217.58% | -737.14% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Rhythm Pharmaceuticals, Inc.
关于Rhythm Pharmaceuticals, Inc.（RYTM）损益表
Rhythm Pharmaceuticals, Inc.（RYTM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，RYTM实现营收$0.19B，毛利润$0.17B（毛利率89.73%），净利润($0.20B)（净利率-103.57%）。
常见问题
RYTM · 4 问Rhythm Pharmaceuticals, Inc.（RYTM）2025财年营收为$0.19B，同比up45.8%。
RYTM revenueRYTM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08